Neuropathic Pain Market and Forecast Analysis to 2026

Datamonitor Healthcare estimates the neuropathic pain market to total $8.5bn in 2017 across the US, Japan, and five major EU markets (France, Germany, Italy, Spain, and the UK). Neuropathic pain sales will decline at a CAGR of -2.2% over 2017–26, peaking at $8.9bn in 2018 before contracting due to Lyrica’s patent cliff.
Read more...

;